These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11835913)

  • 61. Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.
    Davlouros PA; Arseniou A; Hahalis G; Chiladakis J; Mazarakis A; Damelou A; Karakantza M; Paliogianni F; Karogiannis N; Alexopoulos D
    Am Heart J; 2009 Oct; 158(4):585-91. PubMed ID: 19781418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction.
    Gabriel AS; Ahnve S; Wretlind B; Martinsson A
    J Intern Med; 2000 Jul; 248(1):61-6. PubMed ID: 10947882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment.
    Garg R; Tellez A; Alviar C; Granada J; Kleiman NS; Lev EI
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):205-9. PubMed ID: 18651648
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Results of percutaneous coronary angioplasty in patients with stable and unstable angina].
    Unikas R; Vaicekavicius E; Navickas R; Jarusevicius G; Janavicius A; Audickas D; Grinius V
    Medicina (Kaunas); 2004; 40 Suppl 1():103-5. PubMed ID: 15079114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention.
    Qi X; Li J; Gu J; Li S; Dang Y; Wang T
    Jpn Heart J; 2003 Jul; 44(4):451-61. PubMed ID: 12906027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease.
    Sheiban I; Leonardo F; Rosano GM; Pagnotta P; Marsico F; Montorfano M; Di Mario C; Trevi G; Colombo A
    Ital Heart J; 2000 Jul; 1(7):480-6. PubMed ID: 10933331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of troponin I after elective percutaneous coronary interventions.
    Drzewiecka-Gerber A; Drzewiecki J; Wita K; Krauze J; Jaklik A; Trusz-Gluza M; Mróz I
    Kardiol Pol; 2004 Aug; 61(8):117-26; discussion 126. PubMed ID: 15457278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris.
    Benamer H; Steg PG; Benessiano J; Vicaut E; Gaultier CJ; Boccara A; Aubry P; Nicaise P; Brochet E; Juliard JM; Himbert D; Assayag P
    Am J Cardiol; 1998 Oct; 82(7):845-50. PubMed ID: 9781965
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.
    Glaser R; Selzer F; Jacobs AK; Laskey WK; Kelsey SF; Holper EM; Cohen HA; Abbott JD; Wilensky RL
    Am J Cardiol; 2006 Dec; 98(11):1446-50. PubMed ID: 17126647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study.
    Sels JW; Tonino PA; Siebert U; Fearon WF; Van't Veer M; De Bruyne B; Pijls NH
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1183-9. PubMed ID: 22115657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials.
    Iijima R; Byrne RA; Ndrepepa G; Braun S; Mehilli J; Berger PB; Schömig A; Kastrati A
    Heart; 2009 Feb; 95(2):107-12. PubMed ID: 18801777
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods.
    Naidu SS; Polin GM; Selzer F; Laskey WK; Jacobs AK; Williams DO; Wilensky RL
    Am J Cardiol; 2006 Aug; 98(4):447-52. PubMed ID: 16893695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am J Med; 2003 Jun; 114(9):715-22. PubMed ID: 12829197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
    Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
    Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
    Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
    Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
    Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
    Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.